Trial Profile
A study on the efficacy and safety of ipragliflozin monotherapy or combination therapy under clinical use condition: continuous glucose monitoring and self monitoring of urine glucose
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2015
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Jul 2015 Status changed from recruiting to completed as per University Hospital Medical Information Network - Japan.
- 15 Aug 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan
- 23 Jul 2014 New trial record